Study Information
Study Details
View study details on clinicaltrials.gov.
Locations
Clinical Trial FAQs
Information for patients and study volunteers, including frequently asked questions.
Description
A Phase 3 Study of Androgen Annihilation in High-Risk Biochemically Relapsed Prostate Cancer
Principal Investigator
Co-Investigator(s)
Glenn D. Wong, D.O., David S. Leibowitz, M.D., FACP, Gillian L. Hsieh, M.D., Edmund W. Tai, M.D., Albert Pisani, M.D., Derrick Wong, M.D., Michael C. Wu, M.D., Irene Wu, M.D., Huan T. Ha, M.D., Natalia Colocci, M.D., Ph.D., Kim-Son Nguyen, M.D., Monique de Bruin, M.D., MPH, Paula D. Kushlan, M.D., M. Dwight Chen, M.D., Janet Wang, M.D., Priya Chakravarthi, M.D.
Related Studies
Genomic Health Oncotype DX AR-V7
Investigators: Kristie A. Bobolis, M.D., Sivakumar Reddy, M.D., Vijay Suhag, M.D., Kristin N. Arreola, M.D., Nitin Rohatgi, MD, Brian K. Kim, M.D, Rajeswari Chellappah, M.D., David S Yee, M.D., MPH